MSFT vs NOW: Which Is the Better Buy?

Side-by-side comparison of Microsoft Corporation and ServiceNow, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-17.
Microsoft Corporation Β· Technology
$497.12
+41.3% upside to fair value
High Conviction Grade A High Quality
VS
ServiceNow, Inc. Β· Technology
$139.82
+16.2% upside to fair value
Med Conviction Grade A- High Quality
QuantHub Verdict
MSFT has more upside to fair value (+41.3%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MSFT NOW
Current Price $497.12 $139.82
Fair Value Estimate $702.35 $162.50
Upside to Fair Value +41.3% +16.2%
Market Cap $3,691.4B $144.6B
Forward P/E β€” β€”
EV / EBITDA 18.3x 43.1x
Price / Sales 11.1x 9.8x
Price / FCF 55.1x 31.5x
Revenue Growth YoY +17.7% +24.0%
Gross Margin 67.9% 74.8%
Operating Margin 46.8% 11.4%
Return on Equity 33.2% 13.8%
Dividend Yield 0.73% 0%
FCF Yield 1.81% 3.17%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
MSFT β€” Microsoft Corporation
Microsoft is a global infrastructure-software platform spanning Azure, Microsoft 365, security, Dynamics, Windows, GitHub and AI copilots, with high business quality supported by enterprise distribution, explicitly cited switching costs, a $678 billion commercial RPO balance, 67.9% TTM gross margin, 46.8% TTM operating margin, 40.3% TTM net margin and 33.2% ROE. Revenue grew 17.7% and earnings gr…
NOW β€” ServiceNow, Inc.
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Accumulation Zones
Metric MSFT NOW
Zone Low $526.76 $121.88
Zone High $597.00 $138.12
In Buy Zone? Yes No
← MSFT Research    NOW Research β†’    All Research